Loading...

Home
ETF
TAK

TAK

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TAK News

Next-Gen CNS Assets Attract Investor Interest

5d agoPRnewswire

Next-Gen CNS Assets Attract Investor Interest

5d agoNewsfilter

Iambic Partners with Takeda for AI Drug Discovery Collaboration

Iambic Signs $1.7B Multi-Year Deal with Takeda for AI Drug Development

6d agoseekingalpha

Takeda (TAK) Q2 2025 Earnings Call Transcript

Feb 05 2026NASDAQ.COM

Alvotech's AVT80 Biosimilar Study Achieves Success

Feb 05 2026seekingalpha

Takeda Pharmaceutical Q3 2025 Earnings Report Analysis

Jan 29 2026Benzinga

Takeda Updates FY2025 Revenue Guidance Amid Cost Discipline

Jan 29 2026seekingalpha

Takeda Reports Q3 FY2025 Earnings Results with Updated Guidance

Jan 29 2026Businesswire

Takeda Pharmaceutical Reports Q3 FY2025 Earnings Results

Jan 29 2026Newsfilter

Trump Administration Launches Medicare Drug Price Negotiations

Jan 28 2026Newsfilter

Takeda Pharmaceutical to Announce Q3 Earnings on January 29

Jan 28 2026seekingalpha

US Expands Medicare Drug Price Negotiation Scope

Jan 28 2026Benzinga

Halozyme Therapeutics (HALO) Partners with Takeda, Price Target Raised to $90

Jan 23 2026Yahoo Finance

Takeda Launches GAMMAGARD LIQUID ERC for Immunodeficiency Treatment

Jan 22 2026NASDAQ.COM

Halozyme and Takeda Sign Exclusive Collaboration for ENTYVIO Development

Jan 08 2026Yahoo Finance